The page is the record's research on the issuer — no analyst, no rating, no view. # Clinuvel Pharmaceuticals Ltd (NASDAQ: CUVL) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Clinuvel Pharmaceuticals Ltd, listed on NASDAQ under ticker CUVL, with ISIN US1887691038 and LEI 5299004VJH3VCYLK6519. Its security type is non-operating entity type (other), its segment is not on the record, its sector is 8880 American Depositary Receipts, and its jurisdiction is Australia. Its listing status is listed, not halted. ## The disclosure read The record holds 35 filings across 28 filing days in the window 2025-11-08 to 2026-11-08, comprising 1 prospectus, 18 regulatory filings and 16 results. The median gap between filing days is 8 days, and the median latency from the latest filing to the record date is 9 days. The NASDAQ median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. The sector node 8880 American Depositary Receipts has one issuer, so no median is stated. The latest filing is dated 2026-10-30 and is of type results. ## Auditor The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag. Its location is not on the record. The record holds no auditor changes. ## Events and halts The record holds one listing dated 2026-07-17. It holds no delisting, no name change, and no dated domicile change, and the segment move is not on the record. The issuer is listed, not halted. ## Orderability The orderability outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 8 research houses: Bioshares, MA Moelis Australia, Jefferies Australia, Morningstar, Wilsons Advisory, Bell Potter Securities, Morgans Financial and Barrenjoey. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001290877.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/CUVL (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.clinuvel.com/investor/analyst-coverage/ (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/CUVL (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CUVL · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp